Auro Laboratories Ltd.
BSE: 530233 | Sector: Health care |
NSE: N.A. | ISIN Code: INE292C01011 |
BSE 00:00 | 20 Apr | 88.70 |
5.80 (7.00%) |
OPEN
84.50 |
HIGH
90.25 |
LOW
81.30 |
NSE 05:30 | 01 Jan | Auro Laboratories Ltd |
OPEN | 84.50 |
PREVIOUS CLOSE | 82.90 |
VOLUME | 59123 |
52-Week high | 128.40 |
52-Week low | 35.15 |
P/E | 9.01 |
Mkt Cap.(Rs cr) | 55 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Auro Laboratories Ltd. (AUROLABS) - Competition
COMPANY | Last Price | Market Cap. (Rs. cr.) |
Sales Turnover | Net Profit | Total Assets |
Sun Pharma.Inds. | 645.05 | 154,766.84 | 12,531.93 | 3,211.14 | 32,355.78 |
Divi's Lab. | 3,783.80 | 100,440.97 | 5,310.57 | 1,372.71 | 7,370.84 |
Dr Reddy's Labs | 5,153.95 | 85,710.19 | 11,850.40 | 2,937.70 | 16,732.90 |
Cipla | 949.30 | 76,556.30 | 12,659.15 | 2,318.17 | 17,704.77 |
Aurobindo Pharma | 987.40 | 57,851.77 | 13,266.48 | 1,872.74 | 16,809.46 |
Cadila Health. | 556.05 | 56,922.84 | 6,347.40 | 1,412.90 | 15,089.80 |
Lupin | 1,090.25 | 49,464.64 | 11,025.66 | 727.55 | 17,937.29 |
Biocon | 401.10 | 48,132.00 | 1,988.40 | 440.90 | 7,583.50 |
Apollo Hospitals | 3,272.85 | 47,057.04 | 9,794.50 | 470.30 | 8,570.00 |
Torrent Pharma. | 2,604.75 | 44,077.58 | 6,168.44 | 938.51 | 10,683.66 |
Gland Pharma | 2,642.55 | 43,232.12 | 2,633.24 | 772.86 | 3,653.86 |
Piramal Enterp. | 1,705.70 | 38,472.06 | 4,219.19 | 144.85 | 33,415.39 |
Alkem Lab | 2,738.95 | 32,744.15 | 6,677.08 | 1,264.42 | 7,728.19 |
Abbott India | 14,860.60 | 31,578.78 | 4,093.14 | 592.93 | 2,691.43 |
Ipca Labs. | 2,157.25 | 27,364.72 | 4,367.43 | 652.46 | 4,185.23 |
Pfizer | 5,480.60 | 25,073.75 | 2,151.65 | 509.13 | 3,534.54 |
Glaxosmi. Pharma | 1,431.95 | 24,258.67 | 3,224.68 | 110.05 | 2,129.60 |
Dr Lal Pathlabs | 2,903.20 | 24,195.27 | 1,273.60 | 223.18 | 1,106.64 |
Syngene Intl. | 598.20 | 23,928.00 | 2,011.90 | 411.50 | 3,313.70 |
Laurus Labs | 443.40 | 23,792.84 | 2,797.34 | 267.05 | 2,966.39 |
Quick Links for Auro Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices